Skip to main content

Table 3 Logistic regression models of potential risk factors and beneficial factors, 6 months postoperatively, according to the three arm morbidities evaluated in the study

From: A comprehensive approach to risk factors for upper arm morbidities following breast cancer treatment: a prospective study

Variable Model 1
Functional disabilities
Model 2
Prolonged pain
Model 3
Decreased ROM
OR (95% CI) P- value OR (95% CI) P- value OR (95% CI) P-value
Risk
Factors
Age 1.07 (0.96–1.19) .852 1.00 (0.96–1.64) .180 1.01 (0.98–1.05) .367
BMI 0.94 (0.76–1.14) .545 0.99 (0.89–1.16) .885 0.98 (0.89–1.08) .737
Tumor Size 0.88 (0.55–1.66) .623 0.98 (0.59–1.64) .986 0.88 (0.55–1.39) .595
In-hospital pain 3.19 (0.83–12.04) .089 2.46 (1.19–5.08) .014* 1.05 (0.61–1.80) .850
Mastectomy 2.71 (0.11–64.90) .299 2.15 (0.75–6.12) .152 1.82 (0.23–13.95) .564
Br. Recons. 7.87 (0.9–68.7) .062 0.83 (0.96–7.27) .871 1.35 (0.17–10.37) .665
Lymph Node 0.85 (0.20–3.58) .834 1.14 (0.97–1.33) .097 1.08 (0.92–1.27 .298
Lymphedema 11.14 (0.17–36.38) .058 33.18 (3.27–336.0) .003* 6.45 (1.04–40.29) .045*
AWS 11.02 (0.92–131.61) .233 14.03 (2.54–77.36) .002* 0.93 (0.20–4.29) .934
Neoadj. Treat. 0.25 (0.03–2.10_ .205 1.58 (0.32–7.76) .571 0.67 (0.20–3.36) .792
Adj. Treat. 0.32 (0.02–3.89) .375 0.93 (0.38–2.26) .889 1.62 (0.55–4.72) .372
Radiotherapy 7.02 (0.54–90.21) .1.34 0.93 (0.28–3.03) .906 3.39 (1.24–9.21) .017*
6 m. Function 1.20 (1.07–1.34) .001* 0.91 (0.84–0.99) .030*
Preop. Pain 0.13 (0.01–0.26) .005* 1.97 (0.95–4.10) .067 0.90 (.562–1.34) .612
Preop. function 0.06 (0.12–0.38) .002* 0.36 (0.08–1.42 .160 0.20 (0.63–0.69) .011*
Preop. ROM 1.03 (0.96–1.11) .343 0.99 (0.94–1.04) .815 0.87 (0.81–0.93) < .001*
Beneficial Factors H. PT. 0.00 (0.01–0.97) .047* 0.13 (0.04–0.38) < .001* 0.26 (0.10–0.70) .008*
PA 0.34 (0.09–1.20 .094 0.41 (0.04–0.33) .105 0.67 (0.43–1.05) .082
  Nagelkerke R2 0.621 Nagelkerke R2 0.619 Nagelkerke R2 0.449
  1. Abbreviations: BMI Body Mass Index, Preop. preoperative, Br. Reccons. Breast Reconstruction, AWS Axillar Web Syndrome, Neoadj. Treat. Neoadjuvant Treatment, adj. Treat. Adjuvant Treatment, 6 m. 6 months, ROM Range of Motion, H. PT. Hospital Physical Therapy, Ph. Act. Physical Activities
  2. *Significan p- value .005